Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #240408 on Elite Pharmaceuticals Inc (ELTP)
namtae
01/25/17 8:55 AM
#240410 RE: WeeZuhl #240408
Nasrat! Pay attention! Screw Pfizer. File ELI-201 NOW with Roxi & Revia as RLD, just like Troxyca did.
carbonfiltered
01/25/17 9:04 AM
#240412 RE: WeeZuhl #240408
NASDAQ2020
01/25/17 9:41 AM
#240419 RE: WeeZuhl #240408
The ELTP King
01/25/17 7:08 PM
#240500 RE: WeeZuhl #240408
Instead of waiting them out... Quote: Pfizer hasn't saved Elite anything yet. If Pfizer doesn't launch then on this assumption means Elite needs to spend $30-70 million more. Lovely. We should smoke them out. Pfizer's Troxyca was an NDA using Roxicodone and Revia as RLD's, exactly like SequestOx. If Pfizer can use an IR oxy as RLD for ER oxy then why cannot we do the exact same? This avoids their 3 year FDA exclusivity and the Paragraph IV notification. Whatever the cost to develop ELI-201, I would think it is all pretty much paid for by now. Rounding out the HAL studies or whatever else is needed to complete the app will be negligible. Nasrat! Pay attention! Screw Pfizer. File ELI-201 NOW with Roxi & Revia as RLD, just like Troxyca did.